Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein. 1979

N Yokosawa, and N Takahashi, and T Inagami, and D L Page

Existing views on prorenin are conflicting and its physiological activation mechanism is not clear. In an attempt to obtain clearcut views on the molecular properties of prorenin in human plasma, the renin zymogen (prorenin) was separated from active renin by two steps of affinity chromatography and it was demonstrated that prorenin is a completely inactivate zymogen contrary to the existing information. Inactive prorenin has an apparent molecular of 56,000 contrary to 46,000-43,000 of partially active prorenin. Isolated and acid-treated human prorenin was shown to be activated by kallikreins from human urine and plasma. This activation was completely blocked by Trasylol. Hog pancreatic kallikrein also activated human prorenin. The kallikrein mediated activation of prorenin indicates the existence of a new link between the vasoconstricting renin-angiotensin system and the vasodilating kallikreinkinin system.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Yokosawa, and N Takahashi, and T Inagami, and D L Page
November 1979, The Journal of clinical endocrinology and metabolism,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
October 1979, Clinical science (London, England : 1979),
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
April 1982, Mineral and electrolyte metabolism,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
December 1978, The American journal of medicine,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
February 1988, The Journal of clinical endocrinology and metabolism,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
December 1979, European journal of clinical investigation,
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
January 1983, Hypertension (Dallas, Tex. : 1979),
N Yokosawa, and N Takahashi, and T Inagami, and D L Page
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!